메뉴 건너뛰기




Volumn 11, Issue 3, 2013, Pages 298-307

Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

EID: 84875879255     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0041     Document Type: Review
Times cited : (18)

References (75)
  • 3
    • 21244499844 scopus 로고    scopus 로고
    • Surgical salvage of recurrent rectal cancer after transanal excision
    • Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005;48:1169-1175.
    • (2005) Dis Colon Rectum , vol.48 , pp. 1169-1175
    • Weiser, M.R.1    Landmann, R.G.2    Wong, W.D.3
  • 4
    • 6044226542 scopus 로고    scopus 로고
    • Preoperative versus postoperative chemoradiotherapy for rectal cancer
    • Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
    • (2004) N Engl J Med , vol.351 , pp. 1731-1740
    • Sauer, R.1    Becker, H.2    Hohenberger, W.3
  • 5
    • 84875518109 scopus 로고    scopus 로고
    • Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
    • Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2009:CD006041.
    • (2009) Cochrane Database Syst Rev
    • Ceelen, W.P.1    Van Nieuwenhove, Y.2    Fierens, K.3
  • 6
    • 84864143836 scopus 로고    scopus 로고
    • What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?
    • Bonnetain F, Bosset JF, Gerard JP, et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer 2012;48:1781-1790.
    • (2012) Eur J Cancer , vol.48 , pp. 1781-1790
    • Bonnetain, F.1    Bosset, J.F.2    Gerard, J.P.3
  • 7
    • 33748676449 scopus 로고    scopus 로고
    • Chemotherapy with preoperative radiotherapy in rectal cancer
    • Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123.
    • (2006) N Engl J Med , vol.355 , pp. 1114-1123
    • Bosset, J.F.1    Collette, L.2    Calais, G.3
  • 8
    • 24944499364 scopus 로고    scopus 로고
    • Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921
    • Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 2005;23:5620-5627.
    • (2005) J Clin Oncol , vol.23 , pp. 5620-5627
    • Bosset, J.F.1    Calais, G.2    Mineur, L.3
  • 9
    • 33750580102 scopus 로고    scopus 로고
    • Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203
    • Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-4625.
    • (2006) J Clin Oncol , vol.24 , pp. 4620-4625
    • Gerard, J.P.1    Conroy, T.2    Bonnetain, F.3
  • 10
    • 79956288407 scopus 로고    scopus 로고
    • Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer
    • Park JH, Yoon SM, Yu CS, et al. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer 2011;117:3703-3712.
    • (2011) Cancer , vol.117 , pp. 3703-3712
    • Park, J.H.1    Yoon, S.M.2    Yu, C.S.3
  • 11
    • 70449726857 scopus 로고    scopus 로고
    • Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03
    • Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-5130.
    • (2009) J Clin Oncol , vol.27 , pp. 5124-5130
    • Roh, M.S.1    Colangelo, L.H.2    O'Connell, M.J.3
  • 12
    • 84860918386 scopus 로고    scopus 로고
    • Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the german CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years
    • Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the german CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30:1926-1933.
    • (2012) J Clin Oncol , vol.30 , pp. 1926-1933
    • Sauer, R.1    Liersch, T.2    Merkel, S.3
  • 13
    • 33947707199 scopus 로고    scopus 로고
    • Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: A review
    • Klautke G, Fietkau R. Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review. Int J Colorectal Dis 2007;22:457-465.
    • (2007) Int J Colorectal Dis , vol.22 , pp. 457-465
    • Klautke, G.1    Fietkau, R.2
  • 14
    • 67650315187 scopus 로고    scopus 로고
    • Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
    • Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009;27:3109-3116.
    • (2009) J Clin Oncol , vol.27 , pp. 3109-3116
    • Andre, T.1    Boni, C.2    Navarro, M.3
  • 15
    • 34250210799 scopus 로고    scopus 로고
    • Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
    • Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198-2204.
    • (2007) J Clin Oncol , vol.25 , pp. 2198-2204
    • Kuebler, J.P.1    Wieand, H.S.2    O'Connell, M.J.3
  • 16
    • 0242578674 scopus 로고    scopus 로고
    • Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer
    • Zhu AX, Willett CG. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. Semin Radiat Oncol 2003;13:454-468.
    • (2003) Semin Radiat Oncol , vol.13 , pp. 454-468
    • Zhu, A.X.1    Willett, C.G.2
  • 17
    • 84864950700 scopus 로고    scopus 로고
    • Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?
    • Hill EJ, Nicolay NH, Middleton MR, Sharma RA. Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research? Crit Rev Oncol Hematol 2012;83:353-387.
    • (2012) Crit Rev Oncol Hematol , vol.83 , pp. 353-387
    • Hill, E.J.1    Nicolay, N.H.2    Middleton, M.R.3    Sharma, R.A.4
  • 18
    • 0037304502 scopus 로고    scopus 로고
    • Chemoradiotherapy: Emerging treatment improvement strategies
    • Milas L, Mason KA, Liao Z, Ang KK. Chemoradiotherapy: emerging treatment improvement strategies. Head Neck 2003;25:152-167.
    • (2003) Head Neck , vol.25 , pp. 152-167
    • Milas, L.1    Mason, K.A.2    Liao, Z.3    Ang, K.K.4
  • 19
    • 0032962339 scopus 로고    scopus 로고
    • Radiopotentiation by the oral platinum agent, JM216: Role of repair inhibition
    • Amorino GP, Freeman ML, Carbone DP, et al. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. Int J Radiat Oncol Biol Phys 1999;44:399-405.
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , pp. 399-405
    • Amorino, G.P.1    Freeman, M.L.2    Carbone, D.P.3
  • 20
    • 0037086328 scopus 로고    scopus 로고
    • Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule
    • Cividalli A, Ceciarelli F, Livdi E, et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 2002;52:1092-1908.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 1092-1908
    • Cividalli, A.1    Ceciarelli, F.2    Livdi, E.3
  • 21
    • 0008590833 scopus 로고    scopus 로고
    • Oxaliplatin: In vitro and in vivo evidence of its radiation sensitizing activity - Preclinical observations relevant to ongoing trials [abstract]
    • Hess S, Blackstock AW. Oxaliplatin: in vitro and in vivo evidence of its radiation sensitizing activity - preclinical observations relevant to ongoing trials [abstract]. Proc Am Assoc Cancer Res 2000;41:Abstract A335.
    • (2000) Proc Am Assoc Cancer Res , vol.41
    • Hess, S.1    Blackstock, A.W.2
  • 22
    • 0141954386 scopus 로고    scopus 로고
    • Oxaliplatin: In vitro evidence of its radiation sensitizing activity - Preclinical observations relevant to clinical trials
    • Blackstock AW, Hess S, Chaney S, Tepper JE. Oxaliplatin: in vitro evidence of its radiation sensitizing activity - preclinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys 1999;45:253-254.
    • (1999) Int J Radiat Oncol Biol Phys , vol.45 , pp. 253-254
    • Blackstock, A.W.1    Hess, S.2    Chaney, S.3    Tepper, J.E.4
  • 23
    • 0037262142 scopus 로고    scopus 로고
    • Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status
    • Magne N, Fischel JL, Formento P, et al. Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status. Oncology 2003;64:280-287.
    • (2003) Oncology , vol.64 , pp. 280-287
    • Magne, N.1    Fischel, J.L.2    Formento, P.3
  • 24
    • 27644493797 scopus 로고    scopus 로고
    • A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: A colorectal clinical oncology group (CCOG) study
    • Sebag-Montefiore D, Glynne-Jones R, Falk S, et al. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a colorectal clinical oncology group (CCOG) study. Br J Cancer 2005;93:993-998.
    • (2005) Br J Cancer , vol.93 , pp. 993-998
    • Sebag-Montefiore, D.1    Glynne-Jones, R.2    Falk, S.3
  • 25
    • 29844435015 scopus 로고    scopus 로고
    • A phase i dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
    • Glynne-Jones R, Sebag-Montefiore D, Maughan TS, et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-56.
    • (2006) Ann Oncol , vol.17 , pp. 50-56
    • Glynne-Jones, R.1    Sebag-Montefiore, D.2    Maughan, T.S.3
  • 26
    • 0035340318 scopus 로고    scopus 로고
    • Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 phase i trial
    • Freyer G, Bossard N, Romestaing P, et al. Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 2001;19:2433-2438.
    • (2001) J Clin Oncol , vol.19 , pp. 2433-2438
    • Freyer, G.1    Bossard, N.2    Romestaing, P.3
  • 27
    • 33745005080 scopus 로고    scopus 로고
    • Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901
    • Ryan DP, Niedzwiecki D, Hollis D, et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006;24:2557-2562.
    • (2006) J Clin Oncol , vol.24 , pp. 2557-2562
    • Ryan, D.P.1    Niedzwiecki, D.2    Hollis, D.3
  • 28
    • 0041912759 scopus 로고    scopus 로고
    • Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer
    • Rodel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003;21:3098-3104.
    • (2003) J Clin Oncol , vol.21 , pp. 3098-3104
    • Rodel, C.1    Grabenbauer, G.G.2    Papadopoulos, T.3
  • 29
    • 25444503968 scopus 로고    scopus 로고
    • A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer
    • Aschele C, Friso ML, Pucciarelli S, et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005;16:1140-1146.
    • (2005) Ann Oncol , vol.16 , pp. 1140-1146
    • Aschele, C.1    Friso, M.L.2    Pucciarelli, S.3
  • 30
    • 28244443399 scopus 로고    scopus 로고
    • Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: A phase i study
    • Francois E, Ychou M, Ducreux M, et al. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study. Eur J Cancer 2005;41:2861-2867.
    • (2005) Eur J Cancer , vol.41 , pp. 2861-2867
    • Francois, E.1    Ychou, M.2    Ducreux, M.3
  • 31
    • 49549098631 scopus 로고    scopus 로고
    • Phase i study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297
    • Rosenthal DI, Catalano PJ, Haller DG, et al. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297. Int J Radiat Oncol Biol Phys 2008;72:108-113.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 108-113
    • Rosenthal, D.I.1    Catalano, P.J.2    Haller, D.G.3
  • 32
    • 33748566796 scopus 로고    scopus 로고
    • A phase i study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
    • Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;65:1462-1470.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 1462-1470
    • Fakih, M.G.1    Rajput, A.2    Yang, G.Y.3
  • 33
    • 20144379288 scopus 로고    scopus 로고
    • Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: A phase i trial
    • Loi S, Ngan SY, Hicks RJ, et al. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer 2005;92:655-661.
    • (2005) Br J Cancer , vol.92 , pp. 655-661
    • Loi, S.1    Ngan, S.Y.2    Hicks, R.J.3
  • 34
    • 16344362642 scopus 로고    scopus 로고
    • Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase i study
    • Reerink O, Mulder NH, Verschueren RC, et al. Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study. Anticancer Res 2005;25:629-633.
    • (2005) Anticancer Res , vol.25 , pp. 629-633
    • Reerink, O.1    Mulder, N.H.2    Verschueren, R.C.3
  • 35
    • 0037445116 scopus 로고    scopus 로고
    • Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial
    • Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-1124.
    • (2003) J Clin Oncol , vol.21 , pp. 1119-1124
    • Gerard, J.P.1    Chapet, O.2    Nemoz, C.3
  • 36
    • 28444461463 scopus 로고    scopus 로고
    • Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study
    • Machiels JP, Duck L, Honhon B, et al. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol 2005;16:1898-1905.
    • (2005) Ann Oncol , vol.16 , pp. 1898-1905
    • MacHiels, J.P.1    Duck, L.2    Honhon, B.3
  • 37
    • 52949095388 scopus 로고    scopus 로고
    • Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma
    • Fakih MG, Bullarddunn K, Yang GY, et al. Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2008;72:650-657.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 650-657
    • Fakih, M.G.1    Bullarddunn, K.2    Yang, G.Y.3
  • 38
    • 34648814228 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the dutch colorectal cancer group
    • Hospers GA, Punt CJ, Tesselaar ME, et al. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the dutch colorectal cancer group. Ann Surg Oncol 2007;14:2773-2779.
    • (2007) Ann Surg Oncol , vol.14 , pp. 2773-2779
    • Hospers, G.A.1    Punt, C.J.2    Tesselaar, M.E.3
  • 39
    • 0036803131 scopus 로고    scopus 로고
    • Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: A phase II IATTGI study
    • Carraro S, Roca EL, Cartelli C, et al. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 2002;54:397-402.
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 397-402
    • Carraro, S.1    Roca, E.L.2    Cartelli, C.3
  • 40
    • 0842326026 scopus 로고    scopus 로고
    • Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas
    • Feng WH, Hong G, Delecluse HJ, Kenney SC. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J Virol 2004;78:1893-1902.
    • (2004) J Virol , vol.78 , pp. 1893-1902
    • Feng, W.H.1    Hong, G.2    Delecluse, H.J.3    Kenney, S.C.4
  • 41
    • 32844470492 scopus 로고    scopus 로고
    • Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer
    • Turitto G, Panelli G, Frattolillo A, et al. Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer. Front Biosci 2006;11:1275-1279.
    • (2006) Front Biosci , vol.11 , pp. 1275-1279
    • Turitto, G.1    Panelli, G.2    Frattolillo, A.3
  • 42
    • 33751268959 scopus 로고    scopus 로고
    • Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer
    • Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006;32:1201-1208.
    • (2006) Eur J Surg Oncol , vol.32 , pp. 1201-1208
    • Urso, E.1    Serpentini, S.2    Pucciarelli, S.3
  • 43
    • 69849105558 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma
    • Feng HY, Li DC, Lou RC, et al. Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2005;8:125-128.
    • (2005) Zhonghua Wei Chang Wai Ke Za Zhi , vol.8 , pp. 125-128
    • Feng, H.Y.1    Li, D.C.2    Lou, R.C.3
  • 44
    • 33747874014 scopus 로고    scopus 로고
    • Alternative clinical end points in rectal cancer - are we getting closer?
    • Glynne-Jones R, Mawdsley S, Pearce T, Buyse M. Alternative clinical end points in rectal cancer - are we getting closer? Ann Oncol 2006;17:1239-1248.
    • (2006) Ann Oncol , vol.17 , pp. 1239-1248
    • Glynne-Jones, R.1    Mawdsley, S.2    Pearce, T.3    Buyse, M.4
  • 45
    • 33748566796 scopus 로고    scopus 로고
    • A phase i study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
    • Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;65:1462-1470.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 1462-1470
    • Fakih, M.G.1    Rajput, A.2    Yang, G.Y.3
  • 46
    • 77950495945 scopus 로고    scopus 로고
    • Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-prodige 2
    • Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-prodige 2. J Clin Oncol 2010;28:1638-1644.
    • (2010) J Clin Oncol , vol.28 , pp. 1638-1644
    • Gerard, J.P.1    Azria, D.2    Gourgou-Bourgade, S.3
  • 47
    • 79960242791 scopus 로고    scopus 로고
    • Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial
    • Aschele C, Cionini L, Lonardi S, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011;29:2773-2780.
    • (2011) J Clin Oncol , vol.29 , pp. 2773-2780
    • Aschele, C.1    Cionini, L.2    Lonardi, S.3
  • 48
    • 84863106037 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
    • Rodel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012;13:679-687.
    • (2012) Lancet Oncol , vol.13 , pp. 679-687
    • Rodel, C.1    Liersch, T.2    Becker, H.3
  • 49
    • 80053103472 scopus 로고    scopus 로고
    • The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]
    • Roh MS, Yothers GA, O'Connell MJ, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]. J Clin Oncol 2011;29(Suppl):Abstract 3503.
    • (2011) J Clin Oncol , vol.29 , Issue.SUPPL.
    • Roh, M.S.1    Yothers, G.A.2    O'Connell, M.J.3
  • 50
    • 0042262630 scopus 로고    scopus 로고
    • Rectal resection with low anastomosis: Functional outcome
    • Matzel KE, Bittorf B, Gunther K, et al. Rectal resection with low anastomosis: functional outcome. Colorectal Dis 2003;5:458-464.
    • (2003) Colorectal Dis , vol.5 , pp. 458-464
    • Matzel, K.E.1    Bittorf, B.2    Gunther, K.3
  • 51
    • 0242410944 scopus 로고    scopus 로고
    • The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation
    • Temple LK, Wong WD, Minsky B. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol 2003;13:469-477.
    • (2003) Semin Radiat Oncol , vol.13 , pp. 469-477
    • Temple, L.K.1    Wong, W.D.2    Minsky, B.3
  • 52
    • 0034118502 scopus 로고    scopus 로고
    • Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation
    • Shibata D, Guillem JG, Lanouette N, et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 2000;43:752-758.
    • (2000) Dis Colon Rectum , vol.43 , pp. 752-758
    • Shibata, D.1    Guillem, J.G.2    Lanouette, N.3
  • 53
    • 0028144915 scopus 로고
    • Long-term functional results of coloanal anastomosis for rectal cancer
    • discussion 94-95
    • Paty PB, Enker WE, Cohen AM, et al. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90-94; discussion 94-95.
    • (1994) Am J Surg , vol.167 , pp. 90-94
    • Paty, P.B.1    Enker, W.E.2    Cohen, A.M.3
  • 54
    • 2342504559 scopus 로고    scopus 로고
    • Are we overtreating rectal cancer: Time for another trial?
    • Carne PW, Nelson H. Are we overtreating rectal cancer: time for another trial? Ann Surg Oncol 2004;11:124-126.
    • (2004) Ann Surg Oncol , vol.11 , pp. 124-126
    • Carne, P.W.1    Nelson, H.2
  • 55
    • 0031947328 scopus 로고    scopus 로고
    • Effect of the introduction of total mesorectal excision for the treatment of rectal cancer
    • Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-529.
    • (1998) Br J Surg , vol.85 , pp. 526-529
    • Carlsen, E.1    Schlichting, E.2    Guldvog, I.3
  • 56
    • 0033504794 scopus 로고    scopus 로고
    • Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service
    • discussion 552-554
    • Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 1999;230:544-552; discussion 552-554.
    • (1999) Ann Surg , vol.230 , pp. 544-552
    • Enker, W.E.1    Merchant, N.2    Cohen, A.M.3
  • 57
    • 0027404137 scopus 로고
    • Mesorectal excision for rectal cancer
    • MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-460.
    • (1993) Lancet , vol.341 , pp. 457-460
    • MacFarlane, J.K.1    Ryall, R.D.2    Heald, R.J.3
  • 58
    • 0035975394 scopus 로고    scopus 로고
    • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    • Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
    • (2001) N Engl J Med , vol.345 , pp. 638-646
    • Kapiteijn, E.1    Marijnen, C.A.2    Nagtegaal, I.D.3
  • 59
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3
  • 60
    • 0034727063 scopus 로고    scopus 로고
    • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
    • Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914.
    • (2000) N Engl J Med , vol.343 , pp. 905-914
    • Saltz, L.B.1    Cox, J.V.2    Blanke, C.3
  • 61
    • 2142703727 scopus 로고    scopus 로고
    • Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    • Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-1214.
    • (2004) J Clin Oncol , vol.22 , pp. 1209-1214
    • Grothey, A.1    Sargent, D.2    Goldberg, R.M.3    Schmoll, H.J.4
  • 62
    • 33744971129 scopus 로고    scopus 로고
    • Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer
    • Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006;29:219-224.
    • (2006) Am J Clin Oncol , vol.29 , pp. 219-224
    • Das, P.1    Skibber, J.M.2    Rodriguez-Bigas, M.A.3
  • 63
    • 11144332468 scopus 로고    scopus 로고
    • Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival
    • discussion 99-101
    • Habr-Gama A, Perez RO, Nadalin W, et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005;9:90-99; discussion 99-101.
    • (2005) J Gastrointest Surg , vol.9 , pp. 90-99
    • Habr-Gama, A.1    Perez, R.O.2    Nadalin, W.3
  • 64
    • 33644842988 scopus 로고    scopus 로고
    • Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
    • Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696.
    • (2005) J Clin Oncol , vol.23 , pp. 8688-8696
    • Rodel, C.1    Martus, P.2    Papadoupolos, T.3
  • 65
    • 23444444903 scopus 로고    scopus 로고
    • Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    • Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-146.
    • (2005) Histopathology , vol.47 , pp. 141-146
    • Ryan, R.1    Gibbons, D.2    Hyland, J.M.3
  • 66
    • 79956219437 scopus 로고    scopus 로고
    • Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence
    • de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 2011;18:1590-1598.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1590-1598
    • De Campos-Lobato, L.F.1    Stocchi, L.2    Da Luz Moreira, A.3
  • 67
    • 23444444903 scopus 로고    scopus 로고
    • Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    • Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-146.
    • (2005) Histopathology , vol.47 , pp. 141-146
    • Ryan, R.1    Gibbons, D.2    Hyland, J.M.3
  • 68
    • 79956159481 scopus 로고    scopus 로고
    • Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
    • Topova L, Hellmich G, Puffer E, et al. Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. Dis Colon Rectum 2011;54:401-411.
    • (2011) Dis Colon Rectum , vol.54 , pp. 401-411
    • Topova, L.1    Hellmich, G.2    Puffer, E.3
  • 69
    • 84857572341 scopus 로고    scopus 로고
    • Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy
    • Huebner M, Wolff BG, Smyrk TC, et al. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg 2012;36:675-683.
    • (2012) World J Surg , vol.36 , pp. 675-683
    • Huebner, M.1    Wolff, B.G.2    Smyrk, T.C.3
  • 70
    • 84864003865 scopus 로고    scopus 로고
    • Neoadjuvant treatment response as an early response indicator for patients with rectal cancer
    • Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 2012;30:1770-1776.
    • (2012) J Clin Oncol , vol.30 , pp. 1770-1776
    • Park, I.J.1    You, Y.N.2    Agarwal, A.3
  • 71
    • 84867402398 scopus 로고    scopus 로고
    • Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: A meta-analysis
    • Zorcolo L, Rosman AS, Restivo A, et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 2012;19:2822-2832.
    • (2012) Ann Surg Oncol , vol.19 , pp. 2822-2832
    • Zorcolo, L.1    Rosman, A.S.2    Restivo, A.3
  • 72
    • 18244396398 scopus 로고    scopus 로고
    • Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival
    • Onaitis MW, Noone RB, Fields R, et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001;8:801-806.
    • (2001) Ann Surg Oncol , vol.8 , pp. 801-806
    • Onaitis, M.W.1    Noone, R.B.2    Fields, R.3
  • 73
    • 77950678271 scopus 로고    scopus 로고
    • Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
    • Sprenger T, Rothe H, Jung K, et al. Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification? World J Surg Oncol 2010;8:27.
    • (2010) World J Surg Oncol , vol.8 , pp. 27
    • Sprenger, T.1    Rothe, H.2    Jung, K.3
  • 74
    • 84861987173 scopus 로고    scopus 로고
    • Postoperative adjuvant chemotherapy in rectal cancer operated for cure
    • Petersen SH, Harling H, Kirkeby LT, et al. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 2012;3:CD004078.
    • (2012) Cochrane Database Syst Rev , vol.3
    • Petersen, S.H.1    Harling, H.2    Kirkeby, L.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.